Login / Signup

Resistant Maltodextrin Consumption in a Double-Blind, Randomized, Crossover Clinical Trial Induces Specific Changes in Potentially Beneficial Gut Bacteria.

Volker MaiAlyssa M BurnsRebecca J SolchJennifer C Dennis-WallMaria UkhanovaBobbi Langkamp-Henken
Published in: Nutrients (2022)
in individuals with low baseline levels of those two species. Potential benefits associated with these microbiota changes remain to be established in studies with quantifiable health-related endpoints.
Keyphrases
  • double blind
  • clinical trial
  • open label
  • placebo controlled
  • phase ii
  • phase iii
  • study protocol
  • case control
  • human health
  • genetic diversity